Benzinga
España
Italia
대한민국
日本
Français
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
Italia
대한민국
日本
Français
Login
Register
Benzinga
Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Recent
Markets
PTSD
Mapping How Ayahuasca Affects Fear Circuits: Key Insights From New Research
TV News Anchor Kendis Gibson Opens Up About Mental Health Struggles And Psychedelic Therapy In New Memoir
VA Funds $1.5M MDMA Study To Treat PTSD In Veterans
TV News Anchor Kendis Gibson Opens Up About Mental Health Struggles And Psychedelic Therapy In New Memoir
VA Funds $1.5M MDMA Study To Treat PTSD In Veterans
Veteran Access To Psychedelic Mental Health Therapies Stalls In Virginia
FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays
Veteran Access To Psychedelic Mental Health Therapies Stalls In Virginia
FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays
FDA Public Meeting Reveals Federal Support For Psychedelics In PTSD Care
Veterans Affairs Eyes Funding For New MDMA-PTSD Trial After FDA Setback
Read More...
PTSD Recent News
Ukraine's Military Veterans Turn To Ketamine For PTSD Treatment As Advocacy Grows
Ketamine therapy is providing fast relief for PTSD in Ukraine's military veterans, offering new hope for the war-torn nation's emotional recovery.
From Vacation To Legal Nightmare: How A Georgia Veteran's CBD Arrest In Dubai Landed Him Behind Bars
A retired Georgia Navy veteran faces drug trafficking charges in Dubai after being arrested for possessing medically prescribed CBD pills.
Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD
MAPS funds a $200K pilot study at Emory University exploring the synergy between MDMA-assisted therapy and Massed Exposure Therapy for PTSD.
FDA Sets September Meeting To Discuss Psychedelic And Other Treatments For PTSD
FDA schedules public meeting to discuss potential psychedelic treatments for PTSD, inviting input from veterans, advocates and researchers
FDA Rejects MDMA For PTSD Treatment, Calls For More Research On Psychedelic Therapy
The FDA this week declined to approve the use of MDMA — popularly known as Ecstasy or Molly — for MDMA-assisted therapy for treating PTSD.
Five Out Of Six Studies On MDMA Show Positive Results, Yet FDA Approval Still Faces Hurdles
A new review finds MDMA therapy for PTSD promising but calls for more research before widespread adoption. Lawmakers urge FDA to reconsider its decision.
Senators Press FDA To Approve MDMA As PTSD Treatment, Stressing US Vets' Suicide Rates As Aug 11 Decision Looms
Bipartisan senators urge FDA to rely on scientific evidence in approving MDMA-Assisted Therapy for PTSD, highlighting its potential to help veterans.
Bipartisan Effort At U.S. Capitol Calls On FDA To Approve MDMA Therapy For Vets And Others With PTSD
Bipartisan lawmakers and veterans push for FDA approval of MDMA therapy for PTSD, marking a milestone in mental health innovation.
How Strategic Real Estate Investments Are Driving Psychedelic Therapy's Growth, Bridging Gaps In Mental Healthcare
Explore how Healing Realty Trust is transforming psychedelic therapy through strategic real estate investments, paving the way for growth.
FDA Committee 'Completely Lost Sight Of The Big Picture' Says Retired Lieutenant General Urging Approval On MDMA For PTSD
FDA Panel Rejects MDMA Therapy For PTSD, Citing Concerns Over Research Data In Setback For Advocates
A committee of advisors to the U.S. Food and Drug Administration (FDA) dealt a blow to the burgeoning field of psychedelic medicine by recommending against the approval of MDMA-assisted therapy as a treatment for PTSD.
Top Federal Drug Official Praises Psychedelics' Potential, Psilocybin And Ketamine On City Health Plans And More
NIDA Director praises psychedelics, NCCIH highlights psilocybin's benefits and Atlanta explores adding psilocybin, ketamine to health plans.
Psychedelics Surpass Cannabis With Unprecedented Bipartisan Support In Congress, Says Top VA Official
Speaking at a Horizons psychedelics conference, VA Under Secretary for Health Shereef Elnahal shared insights on psychedelic medicine
Cannabis And Guns: This Vet Chose The Latter But He Shouldn't Have To, Now He's Going To Federal Court
This vet had to surrender his personal firearms and ammunition or forego the relief provided by medical marijuana. He kept his guns.
Legal Advocate Takes Bold Approach To Address PTSD In Veterans
Courtney Barnes, partner at Feldman Legal Advisors, advocates for psychedelic policy reform, and will be a guest at Benzinga Cannabis Capital Conference.
Groundbreaking: FDA Reviews MDMA Therapy For PTSD, Accepts New Drug Application
Three Key Takeaways:
GOP-Led Senate Bill In Indiana Targets PTSD, Depression With Psilocybin Research For Veterans, First Responders
Indiana legislators are taking aim at mental health and medical issues with a GOP-sponsored Senate bill that would fund state institutions to explore the potential of psilocybin as an alternative treatment for certain mental health disorders.
Veterans Affairs, After Decades, Will Fund Psychedelic Research For Vets With PTSD And Depression
In a groundbreaking move, the U.S. Department of Veterans Affairs (VA) is launching new studies on using psychedelic compounds to treat post-traumatic stress disorder (PTSD) and depression among military veterans.
GOP Candidate Vivek Ramaswamy Wants Legal Psychedelics And Cannabis For PTSD In New Veterans Plan
Vivek Ramaswamy, Republican presidential candidate who famously said he did not approve of Ohio’s cannabis initititive last week despite expressing support for federal legalization, is now saying
Medical Marijuana Program Expands Amid Israel-Hamas Conflict
During the ongoing conflict between Israel and Hamas, Israel's Ministry of Health reported a significant increase in its medical marijuana program.
Gov. Gavin Newsom Vetoes California Psychedelics Bill, Leaves Door Open For New Bill Next Year
California Gov. Gavin Newsom (D) vetoed a bill on Saturday that would have decriminalized the possession and personal use of certain hallucinogens, including psychedelic mushrooms.
Ukraine 'Global Epicenter Of PTSD': Cannabis Can Help, But It's Stuck In Legal Limbo
Military Veteran Empowering Veterans With PTSD In The Cannabis Industry: 'We All Have That Similar Trauma'
Hemp Box ETC founder and CEO Sandy Moore spoke at the recent Benzinga Cannabis Capital Conference in Miami about helping fellow veterans cope with post-traumatic stress disorder (PTSD).
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started